In contrast to all the common oncogenic genetic alterations that are associated with high cancer risk, this SNP was associated with a significantly reduced risk of development of FTC and PIK3CA amplification, adding a novel dimension to the genetic arrays in thyroid tumorigenesis. The gene discussed is PIK3CA; the disease is thyroid cancer, nonmedullary, 2.